Thermo Fisher Scientific Inc (TMO) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally.
Total Assets Chart for Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc (TMO) total assets for FY2025 were USD 110.3B, a 13.4% change from FY2024. Thermo Fisher Scientific Inc's total assets grew from USD 221.7M in 1985 to USD 110.3B in 2025 (49671.3% over 40 years). Total assets compound annual growth rate: 5-year CAGR of 9.8%, 10-year CAGR of 10.5%, 20-year CAGR of 17.7%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $214.46B
- Implied Share Price
- $580.02
- Enterprise Value
- $247.30B
- Revenue (TTM)
- $46.34B
- EBITDA
- $11.74B
- Profit Margin
- 15.04%
- Trailing P/E
- 31.05
- Forward P/E
- 22.47
- Price/Book (MRQ)
- 3.96
- Price/Sales (TTM)
- 4.63
- EV/EBITDA
- 20.53
- EV/Revenue
- 5.34
- Dividend Yield
- 0.31%
- Book Value
- $139.75
- Free Cash Flow (FY2025)
- $6.29B
- Free Cash Flow Yield
- 2.93%
Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.